19 Dec Year in Review 2025
RiverVest Year in Review: 2025...
09 Dec Portfolio Company Bluejay Therapeutics to be Acquired by Mirum Pharmaceuticals
DECEMBER 2025Portfolio Company Bluejay Therapeutics to be Acquired by Mirum Pharmaceuticals ST. LOUIS--(December 8, 2025)-- Bluejay Therapeutics – a RiverVest Venture Fund V portfolio company – has entered into a definitive agreement to be acquired by Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a former RiverVest portfolio company focusing...
14 Oct With $115 Million in Hand, Biotech Startup Eyes the Finish Line
Nicklaus: With $115 Million in Hand, Biotech Startup Eyes the Finish Line...
19 Aug NEWS / RiverVest Mourns Passing of Ronald T. Borchardt, PhD
August 2025RiverVest Mourns Passing of Ronald T. Borchardt, PhD,RiverVest Scientific Advisory Board Member Ronald T. Borchardt, PhDFebruary 18, 1944 - July 15, 2025In MemoriamWith great sadness, RiverVest mourns the passing of Dr. Ronald T. Borchardt, a valued member of our scientific advisory board since 2015. Ron’s...
07 Jul RiverVest Venture Partners Welcomes Brandon Cohen as Analyst
JULY 2025RiverVest Venture Partners Welcomes Brandon Cohen as Analyst Brandon CohenST. LOUIS--(July 8, 2025)--Life sciences venture capital firm RiverVest Venture Partners is pleased to announce that Brandon Cohen has joined the firm as an analyst based in the St. Louis office. Cohen earned a Bachelor of Science in...
28 Feb RIVERVEST NEWS: June Newsletter
RIVERVEST NEWSLETTERJune 2025 Issue RiverVest invites you to read our latest newsletter, featuring:2025 Annual Meeting RecapRiverVest Portfolio: Year in ReviewThe Sugar Fix: A New Approach to Treating a Rare Glycosylation DisorderPortfolio NewsRiverVest News features insights and updates on...
19 Dec Year in Review 2024
RiverVest Year in Review: 2024...
12 Dec RiverVest Welcomes John Cambier and Gary DeCrescenzo to Scientific Advisory Board
ST. LOUIS (December 12, 2024)—RiverVest Venture Partners, a leading life science venture capital firm, today announced that John C. Cambier, Ph.D., and Gary De Crescenzo have joined the firm’s Scientific Advisory Board. Composed of leaders in medical research, RiverVest’s Scientific Advisory Board provides expert guidance...
16 Oct RiverVest Venture Partners Welcomes Nafise Masoumi as Senior Associate
OCTOBER 2024RiverVest Venture Partners Welcomes Nafise Masoumi as Senior Associate Nafise Masoumi, PhDST. LOUIS--(October 16, 2024)--Life sciences venture capital firm RiverVest Venture Partners today announced that Nafise Masoumi, Ph.D. has joined the firm as senior associate based in the San Diego office, where she will focus...
18 Jul RiverVest Venture Partners Promotes Andrew Kleiboeker and Jeff Seitz
JULY 2024RiverVest Venture Partners Announces Promotions ST. LOUIS (July 18, 2024)ST. LOUIS, July 18, 2024– RiverVest Venture Partners today announced the promotions of two members of its team. Andrew Kleiboeker has been promoted to associate, and Jeff Seitz to senior analyst. "Both Andrew and Jeff have shown...
10 Jun Niall O’Donnell, Ph.D. Honored by UC San Diego’s Rady School of Management’s Sullivan Center for Entrepreneurship
June 2024O'Donnell Honored for Entrepreneurial Achievement by UC San Diego's Rady School of Management Niall O'Donnell, Ph.D. RiverVest Managing Director San Diego, CA (June 5, 2024) – UC San Diego’s Rady School of Management named Niall O’Donnell, Ph.D. (Rady MBA Class of 2006) the Sullivan Center for...
13 Dec RiverVest Venture Partners Promotes Karen Spilizewski and Isaac Zike to Managing Director and Pascal Krotee to Principal
DECEMBER 2023RiverVest Venture Partners Promotes Karen Spilizewski and Isaac Zike to Managing Director and Pascal Krotee to Principal ST. LOUIS (December 14, 2023)ST. LOUIS, December 14, 2023 – RiverVest Venture Partners today announced the promotions of three current team members: Karen Spilizewski and Isaac Zike, Ph.D....
03 Nov Pascal Krotee Wins Life Science Catalyst Award
November 2023RiverVest's Pascal Krotee Wins Life Science Catalyst Award Pascal Krotee, Ph.D. RiverVest Senior Associate San Diego, CA (November 1, 2023) – Biocom California today announced the winners of its Eighth Annual Life Science Catalyst Award. RiverVest Senior Associate Pascal Krotee, Ph.D. was among 10 life science...
25 Jul Niall O’Donnell Discusses State of Biotech VC with St. Louis Business Journal
July 2023RiverVest's Niall O'Donnell Discusses State of Biotech VC in 2023 RiverVest Managing Director Niall O'Donnell, Ph.D.ST. LOUIS, MO (July 21, 2023) – From the St. Louis Business Journal, Beyond the List: St. Louis area's largest venture capital firms report managing $9B in capital.“Our newest List...
10 Mar NEWS / RiverVest Mourns Passing of William A. Peck, MD
March 2023RiverVest Mourns Passing of William A. Peck, MD,RiverVest Scientific Advisory Board Founding Member /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} William A. Peck, MDSeptember 28, 1933 - February 22, 2023In MemoriamWe mourn the passing of William A. Peck, MD, who as the...
07 Sep ANNOUNCEMENT / Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics
SEPT 2022Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 7, 2022)Read the Press ReleaseGood Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive...